As per the latest report by ICRA, Indian pharma industry is likely to grow at 9-11% in FY22, on the back of strong demand from emerging markets. EMs are expected to see 13-15% growth, Indian markets 14-16% while Europe will grow 9-11% in FY22. ICRA expects OPMs and NPMs to also be strong in FY22.
As per the latest report by ICRA, Indian pharma industry is likely to grow at 9-11% in FY22, on the back of strong demand from emerging markets. EMs are expected to see 13-15% growth, Indian markets 14-16% while Europe will grow 9-11% in FY22. ICRA expects OPMs and NPMs to also be strong in FY22.